Newly-released Medical Disposables industry analysis report by Future Market Insights reveals that global sales of medical disposables in 2022 were held at US$ 153.5 Billion. With a CAGR of 7.1% from 2023 to 2033, the market is projected to reach a valuation of US$ 326.4 Billion by 2033. Bandages & Wound Dressings is expected to be the highest revenue-generating product type, which is expected to surge at a CAGR of 6.8% from 2023 to 2033.
Attribute | Details |
---|---|
Global Medical Disposables Market (2023) | US$ 163.6 Billion |
Global Medical Disposables Market (2033) | US$ 326.4 Billion |
Global Medical Disposables Market CAGR (2023 to 2033) | 7.1% |
USA Medical Disposables Market CAGR (2023 to 2033) | 6.9% |
Key Companies Profiled | Medline Industries, Inc.; Smith & Nephew PLC; Bayer AG; Becton Dickinson and Company; 3M; Cardinal Health; Johnson & Johnson; Abbott; Medtronic; B Braun Melsungen AG |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As per the Medical Disposables industry research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2018 to 2022, the market increased at around 6.3% CAGR, wherein, countries such as the USA, China, Japan, United kingdom, and South Korea held a significant share in the global market.
Medical disposables are disposable materials including gloves, robes, and face masks used by medical workers to protect their hands from contamination and illness when they come in contact with a patient. Medical disposables have been used since the early 1800s when they were constructed of cotton wool, lint bandages, and paper dressings that did not protect the wearer from chemical or biological agents. New material has been produced throughout time that is not only more effective in terms of protection but also less expensive, to fulfill the demands of all healthcare facilities, large and small.
The rising incidence of Hospital Acquired Infections, an increasing number of surgical procedures, and the growing prevalence of chronic diseases leading to longer hospital admission have been the key factors driving the market. Owing to these factors, the medical disposables market is projected to grow at a CAGR of 7.1% over the coming 10 years.
The subsequent spike in the number of chronic illness cases and a rise in the rate of hospitalizations has fueled the field of emergency medical disposables growth. The expansion of the medical disposables market is being fueled by an increase in the prevalence of hospital-acquired illnesses and disorders, as well as a greater focus on infection prevention. For example, the prevalence of healthcare-associated infection in high-income countries ranges from 3.5% to 12%, whereas it ranges from 5.7% to 19.1% in low and medium-income countries.
A growing geriatric population, an increase in the incidence of incontinence issues, mandatory guidelines that must be followed for patient safety at healthcare institutions, and an increase in demand for sophisticated healthcare facilities is driving the medical disposables market.
The market in North America is expected to reach a valuation of US$ 131 Billion by 2033 from US$ 61.7 Billion in 2022. In August 2000, the Food and Drug Administration (FDA) issued guidance concerning healthcare single-use items reprocessed by third parties or hospitals. In this guidance, FDA stated that hospitals or third-party reprocessors would be considered manufacturers and regulated in the exact same manner. A newly used single-use device still has to fulfill the criteria for device activation required by its flagship when it was originally manufactured. Such regulations have been creating a positive impact on the medical disposables market in the USA market in specific and the North American market in general.
Medical Disposables Market in the USA is expected to gross an absolute dollar opportunity of US$ 55.3 Billion by 2033. Due to the rising number of surgeries and the presence of key players in the country, the USA accounts for a significant opportunity in the global market. A rise in the number of COVID-19 patients in the country has boosted the demand for medical supplies.
The market in the United kingdom is expected to reach a valuation of US$ 16.5 Billion by 2033. Growing with a CAGR of 6.2% in the forecast period, the market in the country is projected to garner an absolute dollar opportunity of around US$ 7.5 Billion.
In Japan, the market is expected to grow at a CAGR of 5.7% from 2023 to 2033, reaching around US$ 16.8 Billion by 2033. The market in the country is expected to gross an absolute dollar opportunity of US$ 7.1 Billion during the forecast period.
The market in South Korea is expected to reach a valuation of around US$ 15 Billion by 2033, growing at a CAGR of 5.1% from 2023 to 2033. The market in the country is expected to witness an absolute dollar opportunity of around US$ 5.9 Billion.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Plastic resin-based medical disposables are expected to have a significant market share and is expected to grow at a CAGR of 6.4% during the forecast period. Plastic resins led the market in terms of raw materials, accounting for more than 55% of total revenue in 2022. Medical equipment such as containers, disposable syringes, tubes for intravenous solutions, and various packaging materials for pharmaceuticals are made with plastic resins.
The market is developing due to the rising occurrence of hospital-acquired illnesses and the resulting increased use of disposable goods to minimize the transmission of COVID-19. The availability of many types of plastics with a wide variety of qualities, such as PVC, PP, low and high-density polyethylene, and polystyrene, has broadened the uses of plastics in the healthcare industry.
The key companies in the market are engaged in mergers, acquisitions and partnerships.
The key players in the market include 3M, Johnson & Johnson Services, Inc., Abbott, Becton, Dickinson & Company, Medtronic, B. Braun Melsungen AG, Bayer AG, Smith and Nephew, Medline Industries, Inc., and Cardinal Health.
Some of the recent developments of key Medical Disposables providers are as follows:
Similarly, recent developments related to companies offering Medical Disposables have been tracked by the team at Future Market Insights, which are available in the full report.
The market is valued at US$ 163.6 billion in 2023.
The market is expected to record a CAGR of 7.1% through 2033.
Germany is expected to expand at a CAGR of 5.1% from 2023 to 2033.
Plastic resin is poised to stay attractive, projecting a CAGR of 6.4% through 2033.
Medline Industries, Inc., Smith & Nephew PLC, and Bayer AG are key market players.
1. Executive Summary | Medical Disposables Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2023 to 2033
5.3.1. Surgical Instruments & Supplies
5.3.1.1. Would Closures
5.3.1.2. Procedural Kits & Trays
5.3.1.3. Surgical Catheters
5.3.1.4. Surgical Instruments
5.3.1.5. Plastic Surgical Drapes
5.3.2. Infusion and Hypodermic Devices
5.3.2.1. Infusion Devices
5.3.2.2. Hupodermic Devices
5.3.3. Diagnostic & Laboratory Disposables
5.3.3.1. Home Testing Supplies
5.3.3.2. Blood Collection Sets
5.3.3.3. Disposable Labware
5.3.3.4. Others
5.3.4. Bandages and Would Dressings
5.3.4.1. Gowns
5.3.4.2. Drapes
5.3.4.3. Face Masks
5.3.4.4. Others
5.3.5. Sterilization Supplies
5.3.5.1. Sterile Containers
5.3.5.2. Sterilization Wraps
5.3.5.3. Sterilization Indicators
5.3.6. Respiratory Devices
5.3.6.1. Prefilled Inhalers
5.3.6.2. Oxygen Delivery Systems
5.3.6.3. Anethesia Disposables
5.3.6.4. Others
5.3.7. Dialysis Disposables
5.3.7.1. Hemodialysis Products
5.3.7.2. Peritoneal Dialysis Products
5.3.8. Medical & Laboratory Gloves
5.3.8.1. Examination Gloves
5.3.8.2. Surgical Gloves
5.3.8.3. Laboratory Gloves
5.3.8.4. Others
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Raw Materials
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Raw Materials, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Raw Materials, 2023 to 2033
6.3.1. Plastic Resins
6.3.2. Nonwoven Material
6.3.3. Rubber
6.3.4. Metal
6.3.5. Glass
6.3.6. Others
6.4. Y-o-Y Growth Trend Analysis By Raw Materials, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Raw Materials, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By End User , 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User , 2023 to 2033
7.3.1. Hospitals
7.3.2. Home Healthcare
7.3.3. Outpatient/Primary Care Facilities
7.3.4. Others
7.4. Y-o-Y Growth Trend Analysis By End User , 2018 to 2022
7.5. Absolute $ Opportunity Analysis By End User , 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. USA
9.2.1.2. Canada
9.2.2. By Product Type
9.2.3. By Raw Materials
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By Raw Materials
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Product Type
10.2.3. By Raw Materials
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Raw Materials
10.3.4. By End User
10.4. Key Takeaways
11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. United kingdom
11.2.1.2. Spain
11.2.1.3. Germany
11.2.1.4. Italy
11.2.1.5. France
11.2.1.6. Rest of Europe
11.2.2. By Product Type
11.2.3. By Raw Materials
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By Raw Materials
11.3.4. By End User
11.4. Key Takeaways
12. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. India
12.2.1.2. China
12.2.1.3. Japan
12.2.1.4. Australia
12.2.1.5. Rest of Asia Pacific
12.2.2. By Product Type
12.2.3. By Raw Materials
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By Raw Materials
12.3.4. By End User
12.4. Key Takeaways
13. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. South Africa
13.2.1.2. GCC Countries
13.2.1.3. Rest of Middle East and Africa
13.2.2. By Product Type
13.2.3. By Raw Materials
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By Raw Materials
13.3.4. By End User
13.4. Key Takeaways
14. Key Countries Market Analysis
14.1. USA
14.1.1. Pricing Analysis
14.1.2. Market Share Analysis, 2022
14.1.2.1. By Product Type
14.1.2.2. By Raw Materials
14.1.2.3. By End User
14.2. Canada
14.2.1. Pricing Analysis
14.2.2. Market Share Analysis, 2022
14.2.2.1. By Product Type
14.2.2.2. By Raw Materials
14.2.2.3. By End User
14.3. Brazil
14.3.1. Pricing Analysis
14.3.2. Market Share Analysis, 2022
14.3.2.1. By Product Type
14.3.2.2. By Raw Materials
14.3.2.3. By End User
14.4. Mexico
14.4.1. Pricing Analysis
14.4.2. Market Share Analysis, 2022
14.4.2.1. By Product Type
14.4.2.2. By Raw Materials
14.4.2.3. By End User
14.5. United kingdom
14.5.1. Pricing Analysis
14.5.2. Market Share Analysis, 2022
14.5.2.1. By Product Type
14.5.2.2. By Raw Materials
14.5.2.3. By End User
14.6. Spain
14.6.1. Pricing Analysis
14.6.2. Market Share Analysis, 2022
14.6.2.1. By Product Type
14.6.2.2. By Raw Materials
14.6.2.3. By End User
14.7. Germany
14.7.1. Pricing Analysis
14.7.2. Market Share Analysis, 2022
14.7.2.1. By Product Type
14.7.2.2. By Raw Materials
14.7.2.3. By End User
14.8. Italy
14.8.1. Pricing Analysis
14.8.2. Market Share Analysis, 2022
14.8.2.1. By Product Type
14.8.2.2. By Raw Materials
14.8.2.3. By End User
14.9. France
14.9.1. Pricing Analysis
14.9.2. Market Share Analysis, 2022
14.9.2.1. By Product Type
14.9.2.2. By Raw Materials
14.9.2.3. By End User
14.10. India
14.10.1. Pricing Analysis
14.10.2. Market Share Analysis, 2022
14.10.2.1. By Product Type
14.10.2.2. By Raw Materials
14.10.2.3. By End User
14.11. China
14.11.1. Pricing Analysis
14.11.2. Market Share Analysis, 2022
14.11.2.1. By Product Type
14.11.2.2. By Raw Materials
14.11.2.3. By End User
14.12. Japan
14.12.1. Pricing Analysis
14.12.2. Market Share Analysis, 2022
14.12.2.1. By Product Type
14.12.2.2. By Raw Materials
14.12.2.3. By End User
14.13. Australia & New Zealand
14.13.1. Pricing Analysis
14.13.2. Market Share Analysis, 2022
14.13.2.1. By Product Type
14.13.2.2. By Raw Materials
14.13.2.3. By End User
14.14. South Africa
14.14.1. Pricing Analysis
14.14.2. Market Share Analysis, 2022
14.14.2.1. By Product Type
14.14.2.2. By Raw Materials
14.14.2.3. By End User
14.15. GCC Countries
14.15.1. Pricing Analysis
14.15.2. Market Share Analysis, 2022
14.15.2.1. By Product Type
14.15.2.2. By Raw Materials
14.15.2.3. By End User
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Product Type
15.3.3. By Raw Materials
15.3.4. By End User
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. Abbott Laboratories
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.2. 3M
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.3. Bayer
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.4. Becton, Dickinson and Company
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.5. Pfizer
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.6. Boston Scientific
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segments
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.7. Medtronic Plc
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segments
16.1.7.4. Sales Footprint
16.1.7.5. Strategy Overview
16.1.7.5.1. Marketing Strategy
16.1.8. Johnson and Johnson
16.1.8.1. Overview
16.1.8.2. Product Portfolio
16.1.8.3. Profitability by Market Segments
16.1.8.4. Sales Footprint
16.1.8.5. Strategy Overview
16.1.8.5.1. Marketing Strategy
16.1.9. Smith and Nephew
16.1.9.1. Overview
16.1.9.2. Product Portfolio
16.1.9.3. Profitability by Market Segments
16.1.9.4. Sales Footprint
16.1.9.5. Strategy Overview
16.1.9.5.1. Marketing Strategy
16.1.10. Cardinal Health
16.1.10.1. Overview
16.1.10.2. Product Portfolio
16.1.10.3. Profitability by Market Segments
16.1.10.4. Sales Footprint
16.1.10.5. Strategy Overview
16.1.10.5.1. Marketing Strategy
17. Assumptions & Acronyms Used
18. Research Methodology
Explore Healthcare Insights
View Reports